IN | Aktsiad | 582,96 M | 1153 | IN Invesco | 0,14 | Tervishoiu | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 905,89 | 5,12 | 22,97 |
SP | Aktsiad | 579,44 M | 11 313 | SP SPDR | 0,15 | Tervishoiu | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 50,39 | 4,86 | 22,63 |
IN | Aktsiad | 558,37 M | 38 751 | IN Invesco | 0,58 | Tervishoiu | Dynamic Pharmaceutical Intellidex Index (AMEX) | 23.6.2005 | 125,76 | 3,12 | 18,42 |
FU | Aktsiad | 532,22 M | — | FU Fullgoal | 0,60 | Tervishoiu | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,94 | 0,00 | 0,00 |
GU | Aktsiad | 508,01 M | — | GU Guotai | 0,60 | Tervishoiu | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,75 | 3,53 | 27,58 |
VA | Aktsiad | 505,76 M | 8828 | VA VanEck | 0,35 | Tervishoiu | MVIS US Listed Biotech 25 | 20.12.2011 | 248,35 | 4,63 | 23,20 |
CH | Aktsiad | 489,93 M | — | CH ChinaAMC | 0,60 | Tervishoiu | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,83 | 2,64 | 31,04 |
SP | Aktsiad | 450,9 M | 151 800 | SP SPDR | 0,35 | Tervishoiu | S&P Pharmaceuticals Select Industry | 19.6.2006 | 63,95 | 3,51 | 16,73 |
| Aktsiad | 444,03 M | — | MO Motilal Oswal | 1,00 | Tervishoiu | BSE Healthcare Index - INR - Benchmark TR Gross | 29.7.2022 | 48,05 | 5,07 | 36,04 |
IN | Aktsiad | 431,71 M | 22 863 | IN Invesco | 0,59 | Tervishoiu | Dynamic Biotech & Genome Intellidex Index (AMEX) | 23.6.2005 | 99,47 | 4,40 | 17,88 |
IS | Aktsiad | 431,47 M | 59 028 | IS iShares | 0,18 | Tervishoiu | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 3.11.2021 | 5,54 | 4,73 | 22,23 |
CS | Aktsiad | 416,91 M | — | CS China Southern | 0,20 | Tervishoiu | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,65 | 3,14 | 28,61 |
| Aktsiad | 405,18 M | — | MA Maxwealth | 0,60 | Tervishoiu | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,39 | 0,00 | 0,00 |
EV | Aktsiad | 360,17 M | 22 071 | EV Evolve | 0,45 | Tervishoiu | Solactive Global Healthcare 20 CAD Hedged Index - CAD | 23.10.2017 | 18,29 | 4,23 | 21,55 |
AM | Aktsiad | 354,99 M | — | AM Amundi | 0,18 | Tervishoiu | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net | 20.9.2022 | 10,66 | 4,64 | 21,76 |
LG | Aktsiad | 353,33 M | 5849 | LG L&G | 0,49 | Tervishoiu | ROBO Global Healthcare Technology and Innovation ETF | 2.7.2019 | 18,64 | 3,12 | 25,07 |
XT | Aktsiad | 332,45 M | 3163 | XT Xtrackers | 0,17 | Tervishoiu | MSCI Europe Health Care ESG Screened 20-35 Index - EUR | 26.6.2007 | 236,53 | 4,15 | 19,55 |
SI | Aktsiad | 324,39 M | 117 431 | SI Simplify | 0,51 | Tervishoiu | | 7.10.2021 | 39,32 | 4,73 | 22,97 |
IN | Aktsiad | 290,31 M | 53 631 | IN Invesco | 0,74 | Tervishoiu | Dorsey Wright Healthcare Tech Leaders TR | 12.10.2006 | 59,61 | 5,92 | 26,92 |
HA | Aktsiad | 290,17 M | — | HA Harvest | 0,60 | Tervishoiu | SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Net | 27.12.2023 | 1,05 | 0,00 | 0,00 |
| Aktsiad | 285,17 M | — | CA Capital | 1,01 | Tervishoiu | NASDAQ / Biotechnology | 9.1.2017 | 36,06 | 4,93 | 21,18 |
IS | Aktsiad | 273,18 M | 105 234 | IS iShares | 0,25 | Tervishoiu | Dow Jones U.S. Select Medical Equipment Capped 35/20 Index | 3.8.2020 | 5,72 | 3,74 | 29,19 |
HA | Aktsiad | 272,27 M | 70 366 | HA Harvest | 0,40 | Tervishoiu | | 21.8.2024 | 10,73 | 0,00 | 0,00 |
HA | Aktsiad | 248,7 M | 41 775 | HA Hamilton | 0,65 | Tervishoiu | | 6.2.2024 | 14,57 | 4,53 | 21,67 |
YI | Alternatiivvara | 244,52 M | 310 496 | YI YieldMax | 1,00 | Tervishoiu | | 23.10.2023 | 43,43 | 0,00 | 0,00 |
HF | Aktsiad | 230,12 M | — | HF Harvest Funds | 0,60 | Tervishoiu | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 16.2.2023 | 0,69 | 2,19 | 38,23 |
SP | Aktsiad | 220,55 M | 31 591 | SP SPDR | 0,35 | Tervishoiu | S&P Health Care Services Select Industry | 28.9.2011 | 140,48 | 2,54 | 15,55 |
TE | Aktsiad | 211,78 M | 31 756 | TE Tema | 0,99 | Tervishoiu | | 14.8.2023 | 41,44 | 6,58 | 19,80 |
PA | Aktsiad | 208,11 M | — | PA Ping An | 0,60 | Tervishoiu | CSI Hong Kong Connect Healthcare - CNY - Benchmark TR Gross | 16.12.2021 | 0,92 | 2,48 | 20,11 |
HA | Aktsiad | 203,39 M | — | HA Harvest | 0,60 | Tervishoiu | CSI Medicine and Health 100 Strategy Index - CNY - Benchmark TR Gross | 24.4.2020 | 0,82 | 2,79 | 22,89 |
HA | Aktsiad | 203,27 M | — | HA Harvest | 0,60 | Tervishoiu | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 7.5.2024 | 1,55 | 2,67 | 20,30 |
| Aktsiad | 195,93 M | — | SY Sygnia | 0,53 | Tervishoiu | | 6.8.2021 | 29,49 | 4,30 | 21,13 |
BM | Aktsiad | 192,39 M | 1488 | BM BMO | 0,39 | Tervishoiu | Solactive Equal Weight U.S. Health Care Hedged to Canada Index - CAD | 19.5.2010 | 81,18 | 3,67 | 20,81 |
CH | Aktsiad | 190,36 M | — | CH ChinaAMC | 0,60 | Tervishoiu | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 28.7.2025 | 0,89 | 0,00 | 0,00 |
AF | Aktsiad | 188,03 M | 42 363 | AF ALPS Funds | 0,50 | Tervishoiu | S-Network Medical Breakthroughs Index | 30.12.2014 | 54,50 | 4,17 | 0,00 |
BE | Aktsiad | 183,53 M | 136 838 | BE BetaShares | 0,57 | Tervishoiu | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | 4.8.2016 | 9,38 | 4,60 | 21,62 |
DI | Aktsiad | 183,33 M | 66 218 | DI Direxion | 0,94 | Tervishoiu | S&P Health Care Select Sector | 15.6.2011 | 152,77 | 4,83 | 22,47 |
GU | Aktsiad | 180,39 M | — | GU Guotai | 0,00 | Tervishoiu | Hang Seng Biotechnology Index - CNY - Benchmark TR Gross | 21.1.2026 | 1,00 | 0,00 | 0,00 |
| Aktsiad | 173,45 M | — | HW Hwabao | 0,60 | Tervishoiu | CSI Hong Kong Connect Healthcare - CNY - Benchmark TR Gross | — | 0,93 | 0,00 | 0,00 |
BO | Aktsiad | 168,87 M | — | BO Bosera | 0,60 | Tervishoiu | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 22.7.2021 | 0,58 | 3,89 | 25,29 |
IN | Aktsiad | 168,17 M | 27 409 | IN Invesco | 0,29 | Tervishoiu | S&P SmallCap 600 Capped Health Care Index - Benchmark TR Gross | 7.4.2010 | 53,56 | 2,51 | 19,03 |
EF | Aktsiad | 165,58 M | — | EF E Fund | 0,00 | Tervishoiu | Hang Seng Biotech Index - CNY - Benchmark TR Gross | 20.10.2025 | 0,97 | 0,00 | 0,00 |
CH | Aktsiad | 157,24 M | — | CH ChinaAMC | 0,60 | Tervishoiu | | 4.3.2021 | 0,62 | 2,79 | 29,27 |
GU | Aktsiad | 155,73 M | — | GU Guotai | 0,60 | Tervishoiu | China Securities Vaccine and Biotechnology Index - Benchmark TR Gross | 10.8.2022 | 0,58 | 0,00 | 0,00 |
IC | Aktsiad | 155,32 M | — | IC ICBC | 0,52 | Tervishoiu | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 9.2.2021 | 0,57 | 3,14 | 28,61 |
SP | Aktsiad | 148,52 M | 29 861 | SP SPDR | 0,35 | Tervishoiu | S&P Healthcare Equipment Select Industry | 26.1.2011 | 91,40 | 2,50 | 21,37 |
MI | Aktsiad | 146,22 M | — | MI Middlefield | 1,36 | Tervishoiu | | 12.2.2019 | 11,40 | 4,83 | 24,11 |
TD | Aktsiad | 143,05 M | 7970 | TD TD | 0,39 | Tervishoiu | Solactive Global Healthcare Leaders Index - CAD - Benchmark TR Net | 7.4.2021 | 21,67 | 3,51 | 20,54 |
EF | Aktsiad | 132,35 M | — | EF E Fund | 0,60 | Tervishoiu | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 31.12.2025 | 0,86 | 0,00 | 0,00 |
VI | etf_assetclass_Sector Equity | 131,11 M | 11 547 | VI Virtus | 0,34 | Tervishoiu | LifeSci Biotechnology Products Index | 16.12.2014 | 104,89 | 5,54 | 0,00 |
IS | Aktsiad | 129,01 M | 10 956 | IS iShares | 0,18 | Tervishoiu | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 15.6.2020 | 8,08 | 0,00 | 0,00 |
| etf_assetclass_Sector Equity | 126,01 M | 4810 | CI CIGlobal | 0,72 | Tervishoiu | | 7.6.2018 | 11,83 | 3,88 | 17,87 |
AM | Aktsiad | 125,69 M | — | AM Amundi | 0,18 | Tervishoiu | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net | 20.9.2022 | 10,22 | 2,89 | 19,72 |
| Aktsiad | 125,35 M | — | SO SOL | 0,45 | Tervishoiu | FnGuide Medical Device Director Index - KRW - Benchmark Price Return | 22.8.2023 | 9285,07 | 2,31 | 17,09 |
HA | Aktsiad | 119,23 M | 64 785 | HA Harvest | 0,01 | Tervishoiu | | 25.10.2022 | 9,02 | 0,00 | 0,00 |
| Aktsiad | 118 M | 3946 | EM Emerald | 0,79 | Tervishoiu | | 30.10.2024 | 42,57 | 6,27 | 0,00 |
FU | Aktsiad | 116,43 M | — | FU Fullgoal | 0,60 | Tervishoiu | Hang Seng Biotech Index - CNY - Benchmark TR Gross | 24.12.2025 | 1,00 | 0,00 | 0,00 |
IN | Aktsiad | 114,79 M | 34 452 | IN Invesco | 0,19 | Tervishoiu | NASDAQ / Biotechnology | 11.6.2021 | 35,21 | 4,91 | 21,12 |
CS | Aktsiad | 114,35 M | — | CS China Southern | 0,60 | Tervishoiu | CSI Full Index of Medical and Healthcare Equipment and Service Index - CNY - Benchmark TR Gross | 22.10.2021 | 0,56 | 2,73 | 32,82 |
KR | Aktsiad | 114,03 M | 78 190 | KR KraneShares | 0,79 | Tervishoiu | MSCI China All Shares Health Care 10/40 Index | 31.1.2018 | 18,24 | 3,41 | 26,60 |
RG | Aktsiad | 111,1 M | 43 090 | RG ROBO Global | 0,80 | Tervishoiu | ROBO Global Healthcare Technology and Innovation ETF | 25.6.2019 | 44,44 | 3,10 | 25,46 |
PR | Aktsiad | 104,6 M | 14 428 | PR ProShares | 1,08 | Tervishoiu | S&P Health Care Select Sector | 30.1.2007 | 65,79 | 0,00 | 0,00 |
HE | Aktsiad | 104,2 M | — | HE Harvest ETFs | 1,06 | Tervishoiu | | 17.1.2017 | 7,83 | 0,00 | 0,00 |
| Aktsiad | 100,55 M | — | SA Satrix | 0,48 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 26.5.2022 | 73,03 | 0,00 | 0,00 |
PR | Aktsiad | 96,28 M | 11 145 | PR ProShares | 1,17 | Tervishoiu | NASDAQ / Biotechnology | 7.4.2010 | 114,62 | 0,00 | 0,00 |
DE | etf_assetclass_Leveraged/Inverse | 95,91 M | 245 057 | DE Defiance | 1,34 | Tervishoiu | | 3.2.2026 | 213,14 | 0,00 | 0,00 |
MI | Aktsiad | 84,3 M | 1274 | MI Middlefield | 0,85 | Tervishoiu | | 21.7.2017 | 10,44 | 0,00 | 0,00 |
CI | Aktsiad | 82,21 M | — | CI CI | 0,56 | Tervishoiu | Solactive Developed Markets Healthcare 150 CAD Index - CAD - Benchmark TR Net | 17.8.2021 | 23,70 | 0,00 | 0,00 |
IS | Aktsiad | 80,33 M | 36 753 | IS iShares | 0,35 | Tervishoiu | NASDAQ / Biotechnology | 5.3.2018 | 10,31 | 4,93 | 21,38 |
CA | Aktsiad | 78,35 M | — | CA Cathay | 0,00 | Tervishoiu | ChiNext Medical and Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,07 | 0,00 | 0,00 |
| Aktsiad | 78,23 M | — | KS KSM | 0,73 | Tervishoiu | S&P Health Care Select Sector | 4.12.2018 | 48,79 | 0,00 | 0,00 |
DI | etf_assetclass_Leveraged/Inverse | 76,62 M | 17,66 M | DI Direxion | 1,08 | Tervishoiu | S&P Biotechnology Select Industry | 28.5.2015 | 7,47 | 0,00 | 0,00 |
BF | Aktsiad | 71,42 M | 3327 | BF Brompton Funds | 0,75 | Tervishoiu | | 24.9.2015 | 7,75 | 6,13 | 23,54 |
| Aktsiad | 69,85 M | 732 191 | LE LeverageShares | 0,75 | Tervishoiu | | 22.7.2025 | 21,76 | 0,00 | 0,00 |
DE | Aktsiad | 62,45 M | 377 749 | DE Defiance | 1,33 | Tervishoiu | | 12.3.2025 | 25,39 | 0,00 | 0,00 |
CH | Aktsiad | 62,41 M | — | CH ChinaAMC | 0,00 | Tervishoiu | Shanghai Stock Exchange Science and Technology Innovation Board Biopharmaceutical Index - CNY - Benchmark TR Gross | 14.5.2025 | 1,08 | 0,00 | 0,00 |
RI | Aktsiad | 56,12 M | 18 805 | RI Roundhill Investments | 0,59 | Tervishoiu | | 21.5.2024 | 30,01 | 4,01 | 14,05 |
TE | Aktsiad | 55,53 M | 4080 | TE Tema | 0,99 | Tervishoiu | | 20.11.2023 | 37,52 | 6,56 | 21,55 |
FI | Aktsiad | 52,31 M | 7751 | FI Fidelity | 0,50 | Tervishoiu | | 16.4.2020 | 31,68 | 4,23 | 37,59 |
VA | Aktsiad | 50,79 M | — | VA VanEck | 0,45 | Tervishoiu | MarketGrader Developed Markets ex-Australia Health Care Index - AUD | 8.9.2020 | 11,35 | 4,95 | 21,34 |
GX | Aktsiad | 47,58 M | 2326 | GX Global X | 0,45 | Tervishoiu | S&P Biotechnology Select Industry | 8.11.2018 | 73,88 | 5,08 | 0,00 |
MI | Aktsiad | 45,87 M | 33 | MI Middlefield | 0,27 | Tervishoiu | | 20.10.2016 | 12,33 | 4,47 | 21,53 |
AD | Aktsiad | 45,22 M | 38 782 | AD AdvisorShares | 1,84 | Tervishoiu | | 15.9.2021 | 20,98 | 3,48 | 0,00 |
DE | etf_assetclass_Leveraged/Inverse | 43,37 M | 330 614 | DE Defiance | 1,49 | Tervishoiu | | 7.8.2024 | 29,01 | 0,00 | 0,00 |
HA | Aktsiad | 42,75 M | 4331 | HA Harbor | 0,80 | Tervishoiu | | 16.11.2022 | 33,53 | 11,65 | 33,30 |
FU | Aktsiad | 40,7 M | — | FU Fullgoal | 0,60 | Tervishoiu | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 16.9.2022 | 0,66 | 2,00 | 29,03 |
VI | etf_assetclass_Sector Equity | 40,28 M | 24 518 | VI Virtus | 0,65 | Tervishoiu | LifeSci Biotechnology Clinical Trials Index | 16.12.2014 | 42,40 | 4,22 | 0,00 |
DE | Aktsiad | 38,99 M | 427 156 | DE Defiance | 1,31 | Tervishoiu | | 2.12.2024 | 9,88 | 0,00 | 0,00 |
IS | Aktsiad | 38,78 M | 7141 | IS iShares | 0,18 | Tervishoiu | | 21.3.2018 | 41,39 | 4,27 | 23,49 |
IS | Aktsiad | 36,79 M | 3797 | IS iShares | 0,18 | Tervishoiu | | 21.3.2018 | 34,13 | 5,85 | 16,28 |
PU | Aktsiad | 36,24 M | — | PU Purpose | 0,00 | Tervishoiu | | 7.2.2025 | 7,98 | 0,00 | 0,00 |
| Aktsiad | 34,22 M | 7397 | TR T. Rowe | 0,44 | Tervishoiu | | 11.6.2025 | 34,22 | 3,97 | 25,60 |
SP | Aktsiad | 32,74 M | 40 388 | SP SPDR | 0,35 | Tervishoiu | S&P Health Care Select Sector | 29.7.2025 | 27,06 | 0,00 | 0,00 |
EV | Aktsiad | 32,67 M | — | EV Evolve | 0,72 | Tervishoiu | Solactive Global Healthcare 20 Index - CAD | 25.10.2017 | 22,60 | 0,00 | 0,00 |
TR | Aktsiad | 32,28 M | 257 847 | TR Tradr | 1,30 | Tervishoiu | | 12.5.2025 | 25,35 | 0,00 | 0,00 |
GX | Aktsiad | 32,2 M | 7881 | GX Global X | 0,50 | Tervishoiu | Global X HealthTech Index - Benchmark TR Net | 29.7.2020 | 30,67 | 3,67 | 26,47 |
| Aktsiad | 31,72 M | — | TA Tachlit | 1,23 | Tervishoiu | NASDAQ / Biotechnology | 13.11.2018 | 152,42 | 0,00 | 0,00 |
SM | etf_assetclass_Sector Equity | 30,96 M | 12 658 | SM Smartshares | 0,75 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 6.6.2019 | 4,21 | 0,00 | 0,00 |
HE | Aktsiad | 30,63 M | — | HE Harvest ETFs | 0,00 | Tervishoiu | | 21.8.2024 | 9,22 | 0,00 | 0,00 |
LG | Aktsiad | 29,17 M | 1573 | LG L&G | 0,49 | Tervishoiu | Solactive Pharma Breakthrough Value Index | 23.1.2018 | 14,72 | 3,62 | 18,36 |